Plain-English translation of NCT06502015 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are looking for biological markers—measurable signs in blood and tissue—that can help doctors better understand autoimmune diseases affecting the nervous system. This study will collect samples from up to 50,000 people with conditions like multiple sclerosis, myasthenia gravis, and related autoimmune disorders, along with healthy volunteers. By studying these samples, scientists hope to find patterns that could improve how these diseases are diagnosed and treated.
Right now, many autoimmune nervous system diseases are hard to diagnose and doctors struggle to predict which patients will respond best to which treatments. This study aims to discover biological markers that could help doctors personalize care and avoid serious side effects by understanding each patient's unique disease better.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will visit the hospital to have blood drawn and possibly provide other tissue samples for testing. Researchers will analyze these samples using advanced techniques to identify biological markers associated with your condition. The study is ongoing and may involve follow-up visits, but most of your participation consists of providing samples once or a few times rather than taking medication or undergoing procedures.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
China